Characterization of human recombinant N-acetylgalactosamine-6-sulfate sulfatase produced in Pichia pastoris as potential enzyme for Mucopolysaccharidosis IVA treatment
- Author
- Alexander Rodríguez-López, Luisa N Pimentel-Vera, Angela J Espejo-Mojica, Annelies Van Hecke (UGent) , Petra Tiels (UGent) , Shunji Tomatsu, Nico Callewaert (UGent) and Carlos J Alméciga-Díaz
- Organization
- Keywords
- Morquio A, mucopolysaccharidosis IV A, GALNS, Pichia pastoris, glycosylations, ACID ALPHA-GLUCOSIDASE, REPLACEMENT THERAPY, ELOSULFASE ALPHA, LYSOSOMAL-ENZYMES, MANNOSE RECEPTOR, PROTEIN GLYCOSYLATION, MEDIATED DELIVERY, N-GLYCOSYLATION, CELLULAR UPTAKE, MORQUIO
Downloads
-
(...).pdf
- full text
- |
- UGent only
- |
- |
- 2.37 MB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8612014
- MLA
- Rodríguez-López, Alexander, et al. “Characterization of Human Recombinant N-Acetylgalactosamine-6-Sulfate Sulfatase Produced in Pichia Pastoris as Potential Enzyme for Mucopolysaccharidosis IVA Treatment.” JOURNAL OF PHARMACEUTICAL SCIENCES, vol. 108, no. 8, 2019, pp. 2534–41, doi:10.1016/j.xphs.2019.03.034.
- APA
- Rodríguez-López, A., Pimentel-Vera, L. N., Espejo-Mojica, A. J., Van Hecke, A., Tiels, P., Tomatsu, S., … Alméciga-Díaz, C. J. (2019). Characterization of human recombinant N-acetylgalactosamine-6-sulfate sulfatase produced in Pichia pastoris as potential enzyme for Mucopolysaccharidosis IVA treatment. JOURNAL OF PHARMACEUTICAL SCIENCES, 108(8), 2534–2541. https://doi.org/10.1016/j.xphs.2019.03.034
- Chicago author-date
- Rodríguez-López, Alexander, Luisa N Pimentel-Vera, Angela J Espejo-Mojica, Annelies Van Hecke, Petra Tiels, Shunji Tomatsu, Nico Callewaert, and Carlos J Alméciga-Díaz. 2019. “Characterization of Human Recombinant N-Acetylgalactosamine-6-Sulfate Sulfatase Produced in Pichia Pastoris as Potential Enzyme for Mucopolysaccharidosis IVA Treatment.” JOURNAL OF PHARMACEUTICAL SCIENCES 108 (8): 2534–41. https://doi.org/10.1016/j.xphs.2019.03.034.
- Chicago author-date (all authors)
- Rodríguez-López, Alexander, Luisa N Pimentel-Vera, Angela J Espejo-Mojica, Annelies Van Hecke, Petra Tiels, Shunji Tomatsu, Nico Callewaert, and Carlos J Alméciga-Díaz. 2019. “Characterization of Human Recombinant N-Acetylgalactosamine-6-Sulfate Sulfatase Produced in Pichia Pastoris as Potential Enzyme for Mucopolysaccharidosis IVA Treatment.” JOURNAL OF PHARMACEUTICAL SCIENCES 108 (8): 2534–2541. doi:10.1016/j.xphs.2019.03.034.
- Vancouver
- 1.Rodríguez-López A, Pimentel-Vera LN, Espejo-Mojica AJ, Van Hecke A, Tiels P, Tomatsu S, et al. Characterization of human recombinant N-acetylgalactosamine-6-sulfate sulfatase produced in Pichia pastoris as potential enzyme for Mucopolysaccharidosis IVA treatment. JOURNAL OF PHARMACEUTICAL SCIENCES. 2019;108(8):2534–41.
- IEEE
- [1]A. Rodríguez-López et al., “Characterization of human recombinant N-acetylgalactosamine-6-sulfate sulfatase produced in Pichia pastoris as potential enzyme for Mucopolysaccharidosis IVA treatment,” JOURNAL OF PHARMACEUTICAL SCIENCES, vol. 108, no. 8, pp. 2534–2541, 2019.
@article{8612014,
author = {{Rodríguez-López, Alexander and Pimentel-Vera, Luisa N and Espejo-Mojica, Angela J and Van Hecke, Annelies and Tiels, Petra and Tomatsu, Shunji and Callewaert, Nico and Alméciga-Díaz, Carlos J}},
issn = {{0022-3549}},
journal = {{JOURNAL OF PHARMACEUTICAL SCIENCES}},
keywords = {{Morquio A,mucopolysaccharidosis IV A,GALNS,Pichia pastoris,glycosylations,ACID ALPHA-GLUCOSIDASE,REPLACEMENT THERAPY,ELOSULFASE ALPHA,LYSOSOMAL-ENZYMES,MANNOSE RECEPTOR,PROTEIN GLYCOSYLATION,MEDIATED DELIVERY,N-GLYCOSYLATION,CELLULAR UPTAKE,MORQUIO}},
language = {{eng}},
number = {{8}},
pages = {{2534--2541}},
title = {{Characterization of human recombinant N-acetylgalactosamine-6-sulfate sulfatase produced in Pichia pastoris as potential enzyme for Mucopolysaccharidosis IVA treatment}},
url = {{http://dx.doi.org/10.1016/j.xphs.2019.03.034}},
volume = {{108}},
year = {{2019}},
}
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: